BNTXBioNTech SE American Depositary Share

ADRCNasdaq (XNAS)·USD

Identity

Security key: 12731
Ticker: BNTX
Type: ADRC — American Depository Receipt Common
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2019-10-10
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: BNTX

Detail

Enriched 2026-08-14 20:47

Market cap: $23,296,692,902.84
Shares outstanding (class): 252,884,261
Shares outstanding (weighted): 251,204,366
SIC: —
Employees: 7,807
Location: —
Homepage: https://www.biontech.de
Description: BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Market cap and share counts drift.

Funds holding this security

76 funds · 79 positions · $1.42B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
Dodge & Cox International Stock Fund Dodge & Cox Funds	—	$223.77M	0.37%	2,517,713 NS	FIGI
T. Rowe Price Capital Appreciation Fund T. ROWE PRICE CAPITAL APPRECIATION FUND, IN…	—	$201.97M	0.31%	2,272,437 NS	FIGI
VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS	—	$194.57M	0.79%	2,189,120 NS	FIGI
Fidelity Contrafund Fidelity Contrafund	—	$181.30M	0.11%	2,039,853 NS	FIGI
T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC.	—	$90.60M	0.40%	1,019,300 NS	FIGI
First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund	FBT	$71.79M	3.16%	807,711 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$53.28M	0.66%	599,506 NS	FIGI
Dodge & Cox Global Stock Fund Dodge & Cox Funds	—	$46.73M	0.39%	525,778 NS	FIGI
MFS Mid Cap Value Fund MFS SERIES TRUST XI	—	$43.82M	0.27%	492,991 NS	FIGI
JNL/T. Rowe Price Capital Appreciation Fund JNL Series Trust	—	$42.87M	0.31%	482,340 NS	FIGI
Fidelity Contrafund K6 Fidelity Contrafund	—	$39.52M	0.12%	444,604 NS	FIGI
T. Rowe Price Capital Appreciation Equity ETF T. Rowe Price Exchange-Traded Funds, Inc.	TCAF	$25.11M	0.40%	282,533 NS	FIGI
VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFO… Voya Investors Trust	—	$20.21M	0.31%	227,361 NS	FIGI
JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust	—	$15.41M	0.38%	173,400 NS	FIGI
Penn Series Flexibly Managed Fund Penn Series Funds Inc	—	$14.82M	0.32%	166,696 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERBNTX
FIGI_COMPOSITEBBG00Q70B3V1
FIGI_SHARE_CLASSBBG00Q70B4L0
CIK0001776985
ISINUS09075V1026
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: BioNTech is a biotechnology company developing mRNA-based therapies and vaccines.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.